|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 111.00 GBX | -0.89% |
|
+4.72% | +6.22% |
| 23/12 | Enwell Energy rocked by Russian military drone attack | AN |
| 22/12 | Eco Animal Health Secures EU Marketing Authorization for Poultry Vaccine | MT |
| Capitalization | 7.52Cr 10Cr 8.68Cr 8.08Cr 14Cr 913.24Cr 15Cr 93Cr 37Cr 436.86Cr 38Cr 37Cr 1.6TCr | P/E ratio 2026 * |
47x | P/E ratio 2027 * | 39.8x |
|---|---|---|---|---|---|
| Enterprise value | 5.42Cr 7.29Cr 6.25Cr 5.82Cr 10Cr 657.96Cr 11Cr 67Cr 26Cr 314.74Cr 27Cr 27Cr 1.15TCr | EV / Sales 2026 * |
0.65x | EV / Sales 2027 * | 0.63x |
| Free-Float |
77.69% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ECO Animal Health Group plc
| 1 day | -0.89% | ||
| 1 week | +4.72% | ||
| Current month | +6.22% | ||
| 1 month | +3.74% | ||
| 3 months | +20.00% | ||
| 6 months | +94.74% | ||
| Current year | +6.22% |
| 1 week | 100 |  | 116.9 |
| 1 month | 97.5 | | 116.9 |
| Current year | 100 | | 116.9 |
| 1 year | 50 | | 116.9 |
| 3 years | 50 | | 135 |
| 5 years | 50 | | 405 |
| 10 years | 50 | | 685 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Hallas
CEO | Chief Executive Officer | 62 | 01/04/2022 |
| Director of Finance/CFO | 62 | 03/09/2019 | |
Jordi Mora
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Armstrong
BRD | Director/Board Member | 69 | 01/05/2020 |
| Director/Board Member | 62 | 19/09/2019 | |
| Chairman | 66 | 01/04/2025 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.89% | +4.72% | +73.44% | +20.00% | 10Cr | |
| +0.98% | -2.71% | -24.34% | -21.80% | 5.49TCr | |
| -0.04% | +2.69% | +108.89% | +86.85% | 1.21TCr | |
| -1.10% | -1.53% | -22.53% | +4.89% | 402.18Cr | |
| -0.28% | +1.41% | +14.81% | +42.49% | 352.45Cr | |
| -0.29% | +7.45% | +172.01% | +67.64% | 271.77Cr | |
| -2.07% | +4.33% | -16.20% | +3.71% | 183.62Cr | |
| -1.46% | +0.83% | +96.69% | +171.41% | 164Cr | |
| -0.55% | +1.27% | +15.29% | +4.79% | 130.31Cr | |
| -1.61% | +0.13% | +28.16% | -37.69% | 117.83Cr | |
| Average | -0.73% | +2.50% | +44.62% | +34.23% | 833.91Cr | |
| Weighted average by Cap. | +0.46% | +1.41% | +7.25% | +5.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.37Cr 11Cr 9.66Cr 9Cr 16Cr 1.02TCr 17Cr 103.44Cr 41Cr 486.28Cr 42Cr 41Cr 1.78TCr | 8.75Cr 12Cr 10Cr 9.4Cr 16Cr 1.06TCr 18Cr 108.12Cr 43Cr 508.27Cr 44Cr 43Cr 1.86TCr |
| Net income | 20.41L 27.46L 23.56L 21.94L 38.09L 25Cr 41.07L 2.52Cr 99.22L 12Cr 1.03Cr 1.01Cr 43Cr | 23.31L 31.35L 26.9L 25.05L 43.5L 28Cr 46.89L 2.88Cr 1.13Cr 14Cr 1.18Cr 1.15Cr 50Cr |
| Net Debt | -2.1Cr -2.83Cr -2.43Cr -2.26Cr -3.92Cr -255.27Cr -4.23Cr -26Cr -10Cr -122.11Cr -11Cr -10Cr -447.45Cr | -2.05Cr -2.75Cr -2.36Cr -2.2Cr -3.82Cr -248.31Cr -4.11Cr -25Cr -9.94Cr -118.78Cr -10Cr -10Cr -435.24Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | 111.00 p | -0.89% | 37,023 |
| 13/26/13 | 112.00 p | -1.75% | 1,12,733 |
| 12/26/12 | 114.00 p | +5.07% | 1,47,080 |
| 09/26/09 | 108.50 p | +4.83% | 1,06,695 |
| 08/26/08 | 103.50 p | -0.96% | 25,953 |
Delayed Quote London S.E., January 14, 2026 at 10:05 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- EAH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition